Prospective pilot study of the pharmacokinetics and pharmacodynamics of interaction between tipranavir/ritonavir and raltegravir in patients infected with HIV-1. [Estudio piloto prospectivo de la farmacocinetica y farmacodinamia de la interaciion entre tipranavir/ritonavir y raltegravir en pacientes infectados por el VIH-1.]

Trial Profile

Prospective pilot study of the pharmacokinetics and pharmacodynamics of interaction between tipranavir/ritonavir and raltegravir in patients infected with HIV-1. [Estudio piloto prospectivo de la farmacocinetica y farmacodinamia de la interaciion entre tipranavir/ritonavir y raltegravir en pacientes infectados por el VIH-1.]

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 07 Jan 2014

At a glance

  • Drugs Raltegravir (Primary) ; Ritonavir; Tipranavir
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 25 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top